Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company’s RAS(ON)
Desktop Administrator L3 Basel, Switzerland Onsite Core Responsibilities Plan and manage full image release lifecycle. Build image with OS layer, drivers, apps (Connect, NORA, Autopilot, etc.). Include all required OS patches, driver updates, core app updates.